Predictors of outcome in cancer patients with candidemia

Annals of Oncology

Volumn 11, Issue 12, 2000, Pages 1517-1521

  Uzun, O ^a   Anaissie, E J ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cancer; Candidemia; Predictive factors; Prognosis

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

BLOOD CULTURE; CANDIDA; CANDIDIASIS; CLINICAL TRIAL; DISEASE SEVERITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0034488811     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008308923252     Document Type: Review

References (19)

1. Morbidity and Mortality Weekly Report: Nosocomial Infection Surveillance: 1983 Surveillance Summaries
2. Predominant pathogens in hospital infections
3. Secular trends in nosocomial primary bloodstream infections in the US, 1980-1989
4. Major trends in the microbial etiology of nosocomial infection
5. Hospital-acquired candidemia: The attributable mortality and excess length of stay
6. Nosocomial fungemia in a large community teaching hospital
7. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: Frequency, characteristics, and evaluation of factors influencing outcome
8. Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality
9. Factors influencing outcome in hospitalized patients with candidemia
10. Therapeutic approaches in patients with candidemia. Evaluation of a multicenter, prospective, observational study
11. Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation
12. Fungemia in patients with leukemia
13. Risk factors for death among cancer patients with fungemia
14. Predictors of adverse outcome in cancer patients with candidemia
15. Candidemia in cancer patients: A prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)
16. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia
17. Correlation between in vitro and in vivo activity of antifungal agents against Candida species
18. Antifungal susceptibility testing of isolates from a randomized multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia
19. Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia